News
Your contact
Gabriele Klingner
Communications & Marketing Lead
Christiane Proll
PR & Social Media Manager
News and articles from BioM about and for the Bavarian biotechnology industry.
-
Gilead acquires Munich-based biotech company and m<sup>4</sup> Award winner Tubulis for up to $5 billion07.04.2026Gilead acquires Munich-based biotech company and m4 Award winner Tubulis for up to $5 billionAmerican biopharmaceutical company Gilead Sciences, located in California, is acquiring the Munich-based biotechnology company Tubulis, thereby further expanding its oncology pipeline. The… -
From idea to application: Bio<sup>M</sup> Bootcamp accelerates biomedical innovations - Coldex convinces with nasal spray26.03.2026From idea to application: BioM Bootcamp accelerates biomedical innovations - Coldex convinces with nasal sprayAs part of this year’s BioEntrepreneur Bootcamp organized by BioM Biotech Cluster GmbH, eleven pre-seed teams took the crucial next step on the path from scientific concept to market-ready… -
BayOConnect 2026: Agenda Expanded with New Sessions, Speakers and Perspectives – Registration Now Open for Europe’s Leading Biotech Forum25.03.2026BayOConnect 2026: Agenda Expanded with New Sessions, Speakers and Perspectives – Registration Now Open for Europe’s Leading Biotech ForumBayOConnect 2026 on 30 June - 1 July 2026 in Munich highlights what truly drives growth in biotechnology: Europe as a competitive innovation hub, capital turning innovation into scale, and… -
BIO-Europe Spring 2026 & LSX World Congress Europe: Bio<sup>M</sup> taking part in the Spring Innovation Week25.03.2026BIO-Europe Spring 2026 & LSX World Congress Europe: BioM taking part in the Spring Innovation WeekBioM took part in BIO‑Europe Spring 2026 and LSX World Congress Europe in Lisbon, representing the Bavarian biotech ecosystem on the international stage. The conferences once again offered an… -
3 million euros for hormone-free contraception: LMU develops new approaches in the PREVENT project20.03.20263 million euros for hormone-free contraception: LMU develops new approaches in the PREVENT projectAn interdisciplinary research team, including members from LMU Munich, is developing novel, non-hormonal contraceptive methods for women and men as part of the PREVENT project. The goal is to… -
Bio<sup>M</sup>’s Crash Course Biotech I 202619.03.2026BioM’s Crash Course Biotech I 2026BioM’s Crash Course Biotech I 2026 (Beginner) offers a comprehensive and interactive introduction to modern biotechnology. The five-week program is designed for beginners, career changers,… -
Bio<sup>M</sup> and LMU Munich agree on strategic collaboration to promote life sciences spin-offs17.03.2026BioM and LMU Munich agree on strategic collaboration to promote life sciences spin-offsBioM Biotech Cluster Development GmbH and Ludwig-Maximilians-Universität (LMU) Munich have signed a memorandum of understanding to intensify their collaboration. The aim of this partnership… -
Bavaria x Australia: Exploring New Models of Global Clinical Trial Collaboration10.03.2026Bavaria x Australia: Exploring New Models of Global Clinical Trial CollaborationClinical trials become more complex and collaborative! This session explores how Australia’s clinical trial ecosystem is structured, its key strengths and efficiencies, and opportunities for… -
BIO-Europe Spring 2026: Bio<sup>M</sup> will attend to represent the Bavarian Biotech Cluster10.03.2026BIO-Europe Spring 2026: BioM will attend to represent the Bavarian Biotech ClusterThis March, BIO-Europe Spring returns for a dynamic in-person experience, and BioM is excited to invite you to join us! From March 23-25 2026, BIO-Europe Spring will take place in Lisbon… -
MPI study identifies new diagnostic markers for multiple sclerosis06.03.2026MPI study identifies new diagnostic markers for multiple sclerosisA large-scale proteomic analysis of cerebrospinal fluid samples has identified new protein markers for the diagnosis of multiple sclerosis (MS). The method, developed at the Max Planck…